End-user preferences for biomedical HIV prevention products and service delivery models
A mixed methods study with female university students in Zambia
Bibliographic Data
| ID | 19439591 |
|---|---|
| Authors | Twaambo E Hamoonga (0000-0001-7375-4610, University of Zambia, corresponding author), K Hampanda (0000-0002-7577-5500, University of Colorado Anschutz Medical Campus), Madeleine Sehrt (0009-0009-7907-0899, University of Colorado Anschutz Medical Campus), Lillian Nayame (0009-0009-4742-2255, University of Zambia), Inyambo Mumbula (0000-0003-2667-5148, University of Zambia), Julia Thorne (0009-0001-2871-7009, University of Colorado Anschutz Medical Campus), Mulanda Joseph Mulawa (0000-0003-4224-0267, University of Zambia), Oliver Mweemba (0000-0002-6941-0193, University of Zambia) |
| Year | 2025 |
| Volume | 37 |
| Issue | 11 |
| Pages | 1857-1867 |
| Publication date | 2025-11-02 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | AIDS Care (JOURNAL) |
| Journal identifiers | ISSN: 0954-0121 • E-ISSN: 1360-0451 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/09540121.2025.2560096 |
| PMID | 41002136 |
| OpenAlex | W4414562937 |
| Language | EN |
| References cited | 22 |
Adolescent girls and young women in sub-Saharan Africa are disproportionately affected by HIV. We determined acceptability and desirability of pre-exposure prophylaxis products and delivery modalities among female university students in Zambia. In 2022, we conducted an online survey (n = 806) and focus group discussions (n = 34) with female students at a public university in Zambia, focused on PrEP products and service delivery preferences. Descriptive statistics and qualitative themes were integrated, compared, and synthesized. The most preferred PrEP products were once-a-month oral pills (35%); a one-time vaccine (33%); and 2-monthly or 3-monthly injection (20%). Few (<5%) preferred the implant, vaginal gel, or vaginal ring. Qualitative themes confirmed preferences for longer-acting PrEP options. However, some participants were hesitant to use an injection and expressed desire for an oral pill that could be taken after sex. Any product that required insertion into the vagina was generally unacceptable and least desired. Most (54%) participants wanted to access PrEP in a non-clinical setting due to anticipated stigma of being seen at an HIV clinic/service area. Expanding PrEP choices, specifically longer-acting and on-demand products, along with differentiated service delivery models beyond the traditional HIV clinic are desirable attributes to female university students in Zambia
Descriptive statistics · Focus group · Microbicides for sexually transmitted diseases · Pill · Pre-exposure prophylaxis · Qualitative property · Qualitative research · Service delivery framework · Adolescent Sexual and Reproductive Health · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions
Achieving Integration in Mixed Methods Designs—Principles and Practices
Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda
Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU)
Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women
Effects of Depression, Stigma and Intimate Partner Violence on Postpartum Women’s Adherence and Engagement in HIV Care in Kenya
Efficacy is Not Everything
Risky Sexual Behaviors and Associated Factors Among College Students in Lusaka, Zambia
| Citation velocity | historical |
|---|---|
| Highly cited | No |